Bcl-2 oncoprotein expression in sweat-gland tumours of the skin

European Journal of Dermatology

Volumn 6, Issue 4, 1996, Pages 307-310

  Narvaez, Daniel ^a   Kanitakis, Jean ^a   Faure, Michel ^a   Claudy, Alain ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Adnexal tumours; Bcl 2; Oncogenes; Skins; Sweat glands

Indexed keywords

ONCOPROTEIN;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; SWEAT GLAND TUMOR;

EID: 0030011478     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Hockenbery D, Nunez G, Milliman C, et al. Bcl-2 is an inner membrane mitochondrial protein that blocks programmed cell death. Nature 1994; 348: 334-6.
2. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994; 124: 1-6.
3. Albrecht H, Tschopp J, Jongeneel C. Bcl-2 protects from oxidative damage and apoptotic cell death without interfering with activation of NF-kappa by TNF. FEBS Lett 1994- 351: 45-8.
4. Hockenbery D, Oltvai Z, Yin XM. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1994; 75: 241-51.
5. 2+ fluxes. Proc Natl Acad Sci USA 1994; 91: 6569-73.
6. Lu Q, Handy AM, Hajibagheri M, et al. Bcl-2 protein localizes to the chromosomes of mitotic nuclei and is correlated with the cell cycle in cultured epithelial cell lines. J Cell Sci 1994; 107: 363-71.
7. Hockenbery D, Zutter M, Hickey W, et al. Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natt Acad Sci USA 1994; 88: 6961-5.
8. Lu QL, Poulsom R, Wong L, Hanby A. Bcl-2 expression in adult and embryonic non-haemopoietic tissues. J Pathol 1993; 169: 431-7.
9. Nathan B, Anbazhagan R, Clarkson P, et al. Expression of Bcl-2 in the developing human fetal and infant breast. Histopathology 1994; 24: 73-6.
10. Smaller B, Van de Rijn M, Lebrun D, Warnke R. Bcl-2 expression reliably distinguishes trichoepitheliomas from basal cell carcinomas. Br J Dermatol 1994; 131: 28-31.
11. Sleater J, Beers B, Stephens C, Hendricks J. Keratoacanthoma: a deficient squamous cell carcinoma? Study of Bcl-2 expression. J Cutan Pathol 1994; 21: 514-9.
12. Cerroni L, Kerl H. Aberrant Bcl-2 protein expression provides a possible mechanism of neoplastic cell growth in cutaneous basal-cell carcinoma. J Cutan Pathol 1994; 21: 398-403.
13. Nakagowa K, Yamamura K, Maeda S, Ichihashi M. Bcl-2 expression in epidermal keratinocytic diseases. Cancer 1994; 74: 1720-4.
14. Saenz-Santamaria M, Reed J, McNutt S, Shea C. Immunohistochemical expression of Bcl-2 in melanomas and intradermal nevi. J Cutan Pathol 1994; 21: 393-7.
15. Van der Ord J, Vandeghinste N, De Ley M, De Wolf-Peters C. Bcl-2 expression in human melanocytes and melanocytic tumors. Am J Pathol 1994; 145: 294-300.
16. Cerroni L, Soyer HP, Kerl H. Bcl-2 expression in cutaneous malignant melanoma and benign melanocytic nevi. Am J Dermatopathol 1995; 17: 7-11
17. Kanitakis J, Montazeri A. Ghohestani R, et al. Bcl-2 oncoprotein expression in benign nevi and malignant melanomas of the skin, Eur J Dermatol 1995; 5: 501-7.
18. Morales-Ducret CR, Van de Rijn M, Smoller B. Bcl-2 expression in melanocytic nevi. Aren Dermatol 1995; 131: 915-8.
19. Marales-Ducret CR, Van de Rijn M, Lebrun P, Smaller B. Bcl-2 expression in primary malignancies of the skin. Aren Dermatol 1995; 131: 909-12.
20. Verhaegh M, Sanders C, Arends J, Neumann H. Expression of the apoptosis-suppressing protein Bcl-2 in non-melanoma skin cancer. Br J Dermatol 1995; 132: 740-4.
21. Ramsay J, From L, Kahn H. Bcl-2 expression in melanocytic neoplasms of the skin. Mod Pathol 1995; 8: 150-4.
22. Plettenberg A, Ballaun C, Pommer J, et al. Human melanocytes and melanoma cells constitutively express the bcl-2 protooncogene in situ and in cell culture. Am J Pathol 1995; 146: 651-9.
23. Cerroni L, Peter Soyer H, Kerl H. Expression of Bcl-2 protein in cutaneous neoplasms: an immunohistochemical study of 259 benign and malignant tumours of the skin. Eur J Dermatol 1995; 5: 619-24.
24. Lever w, Schaumburg-Lever G. Histopathology of the skin. 7th edn. Philadelphia: JB Lippincolt, 1990.
25. Kanitakis J. Immunohistochimie des tumeurs annexielles de la peau. Ann Pathol 1992; 92: 160-4.
26. Wick MR, Swanson R. Cutaneous adnexal tumors. A guide to pathologic diagnosis. Chicago: ASCP, 191.
27. Polakowska R, Piacentini M, Bartlett R. et al. Apoptosis in human skin development: morphogenesis, periderm, and stem cells. Dev Dyn 1994; 199176-88.
28. Rees J. Genetic alterations in non-melanoma skin cancer. J Invest Dermatol 1994; 103: 747-50.
29. Bissonette R, Echeverri F. Mahboubi A, Green D. Apoptotic cell death induced by c-myc is inhibited by Bcl-2. Nature 1994; 359: 552-4.
30. Fanidi A, Harington E, Evan G. Cooperative interaction between c-myc and bcl-2 protooncogenes. Nature 1992; 359: 554-6.
31. Miyashita T, Harigai M, Hanada M, Reed J. Identification of a p53dependent negative response element in the bcl-2 gene. Cancer Res 199454: 3131-5.
32. Mateo MS, Sanchez-Beato M, Martinez J, et al. P53, Rb and Bcl-2 expression during the cell cycle: a study in phytohemagglutinin-stimulated lymphocytes and microwave-irradiated lymphoia tissue sections. J Clin Pathol 1995; 48: 151-9.
33. Green D, Martin S. The killer and the executioner: how apoptosis controls malignancy. Curr Opin Immunol 1995; 7: 694-703.
34. Schwarze M, Hawley R. Prevention of myeloma cell apoptosis by ectopic expression or interleukin-6-mediated upregulation of Bcl-xL. Cancer Res 1995; 55: 2262-5.
35. Norris D. Differential control of cell death in the skin (editorial). Arch Dermatol 1995; 131: 945-8.